Shop

Author at Microdose

Microdose

At our core, we champion integrity, diversity, and objectivity, providing trusted content that unites a wide array of experts and fosters unbiased opinions, ultimately empowering the psychedelic medicine community to flourish and make a positive impact on the world.

Decriminalize psychedelics

Law & Politics

18 Jun 2023

Where Are Psychedelics Legal in the U.S. (or Decriminalized)?

Microdose has put together a list to help you stay updated on where psychedelics are legal or decriminalized in the US....

By Microdose

Health & Wellness

14 Jun 2023

Psychedelics and Longevity: A Holistic Approach to Living Longer

The field of longevity science is gathering almost as much interest as psychedelic medicine is. Do these two fields converge? Can psychedelics improve longevity outcomes?...

By Microdose

Law & Politics

13 Jun 2023

Where Are Psychedelics Legal (or Decriminalized)?

Microdose has put together a list to help you stay updated on where psychedelics are legal or decriminalized....

By Microdose

Law & Politics

10 Jun 2023

A Deeper Look at the Clinical Trial Process and FDA Approval of Psychedelics

An explainer to help you follow your favorite psychedelic medicine through the FDA and clinical trial process...

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Industry

26 May 2023

Terran Biosciences announces new breakthroughs in the chemistry of MDMA and its enantiomers and analogs, discovers new salts and polymorphs, publishes PCT application

Terran Biosciences announces new breakthroughs in the chemistry of MDMA and its enantiomers and analogs, discovers new salts and polymorphs, publishes PCT application...

By Microdose

Health & Wellness

23 May 2023

Mental Health Awareness: Anxiety

May is Mental Health Awareness Month and Microdose is doing its part to support mental health education with a series of informative articles and resources. Today we look at anxiety....

By Microdose

Health & Wellness

19 May 2023

An Introduction to MDMA Therapy

May is Mental Health Awareness Month and Microdose is supporting mental health education with a series of informative articles and resources. Today, we look at MDMA therapy....

By Microdose

Health & Wellness

18 May 2023

Mental Health Awareness: A Look at PTSD

May is Mental Health Awareness Month. Microdose is supporting mental health education with a look at PTSD....

By Microdose

Science

17 May 2023

A Look at the History of MDMA Research

MDMA is on the cusp of FDA approval. To help give context, this article dives into the history of MDMA research...

By Microdose

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

You Might Also Like

17 Dec 2025

Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward

If 2024 was the year the psychedelic field learned how hard “approval ready” really is, 2025 was the year it began behaving accordingly. The past twelve months were less about...

By Madison Roberts

26 Nov 2025

Delix Therapeutics Reports Strong Phase Ib Results

Delix Therapeutics recently announced compelling data from a Phase Ib trial of DLX-001 (zalsupindole), a non-hallucinogenic neuroplastogen. According to the company’s release, DLX-001 produced robust biomarker signals (quantitative EEG and...

By Madison Roberts

19 Nov 2025

Childhood Trauma’s Role in Men’s Substance Use Disorders

Childhood trauma leaves a deeper imprint on men’s lives than most realize—and for many, it becomes the hidden engine driving substance use disorders. Research shows that emotional abuse, physical violence,...

By Madison Roberts

19 Nov 2025

Human-Centered AI in Healthcare

Artificial intelligence is redefining modern healthcare, offering powerful tools that enhance diagnosis, expedite drug discovery, and enable truly personalized treatment. As health systems struggle with rising costs, aging populations, and...

By Madison Roberts

16 Oct 2025

Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up

As Big Pharma makes billion-dollar bets in the evolving landscape of neuropsychiatric therapeutics, Enveric Biosciences (NASDAQ: ENVB) is carving out a formidable position — not by chasing headlines, but by...

By Madison Roberts

15 Oct 2025

The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch

Take Enveric Biosciences (NASDAQ: ENVB), a company that’s been flying under the radar while building an IP fortress around a novel class of non-hallucinogenic neuroplastogens. Now, that fortress is being...

By Madison Roberts
WordPress Ads
No Result
View All Result

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.